|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print October 3, 2001
Am J Physiol Cell Physiol, 10.1152/ajpcell.00119.2001
Submitted on March 8, 2001
Accepted on September 10, 2001
1 Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA
2 GenVec Inc., Gaithersburg, MD, USA
* To whom correspondence should be addressed. E-mail: kibbemr{at}msx.upmc.edu.
The functional role of p53 in NO-mediated VSMC apoptosis remains unknown. In this study, VSMC from p53-/- and p53+/+ murine aortae were exposed to exogenous or endogenous sources of NO. Unexpectedly, p53-/- VSMC were much more sensitive to the pro-apoptotic effects of NO than p53+/+ VSMC. Furthermore, this paradox appeared to be specific to NO as other pro-apoptotic agents did not demonstrate this differential effect on p53-/- cells. NO-induced apoptosis in p53-/- VSMC occurred independent of cGMP generation. However, mitogen-activated protein kinase (MAPK) pathways appeared to play a significant role. Treatment of the p53-/- VSMC with SNAP resulted in a marked activation of p38 MAPK and, to a lesser extent, of JNK, MEK1/2, and p42/44(ERK). Furthermore, basal activity of the MEK-p42/44(ERK) pathway was increased in the p53+/+ VSMC. Inhibition of p38 MAPK with SB203580, or MEK1/2 with PD98059 blocked NO-induced apoptosis. Therefore, p53 may protect VSMC against NO-mediated apoptosis, in part, through differential regulation of MAPK pathways.
This article has been cited by other articles:
![]() |
S. S. Ahanchi, V. N. Varu, N. D. Tsihlis, J. Martinez, C. G. Pearce, M. R. Kapadia, Q. Jiang, J. E. Saavedra, L. K. Keefer, J. A. Hrabie, et al. Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2388 - H2398. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. McLaughlin and B. Demple Nitric Oxide-Induced Apoptosis in Lymphoblastoid and Fibroblast Cells Dependent on the Phosphorylation and Activation of p53 Cancer Res., July 15, 2005; 65(14): 6097 - 6104. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mizuno, M. Kadowaki, Y. Demura, S. Ameshima, I. Miyamori, and T. Ishizaki p42/44 Mitogen-Activated Protein Kinase Regulated by p53 and Nitric Oxide in Human Pulmonary Arterial Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 184 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tian, J. Liu, P. B. Bitterman, and R. J. Bache Mechanisms of cytokine induced NO-mediated cardiac fibroblast apoptosis Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1958 - H1967. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |